Literature DB >> 23445875

Hepcidin level predicts hemoglobin concentration in individuals undergoing repeated phlebotomy.

Alan E Mast1, Karen S Schlumpf, David J Wright, Bryce Johnson, Simone A Glynn, Michael P Busch, Gordana Olbina, Mark Westerman, Elizabeta Nemeth, Tomas Ganz.   

Abstract

Dietary iron absorption is regulated by hepcidin, an iron regulatory protein produced by the liver. Hepcidin production is regulated by iron stores, erythropoiesis and inflammation, but its physiology when repeated blood loss occurs has not been characterized. Hepcidin was assayed in plasma samples obtained from 114 first-time/reactivated (no blood donations in preceding 2 years) female donors and 34 frequent (≥3 red blood cell donations in preceding 12 months) male donors as they were phlebotomized ≥4 times over 18-24 months. Hepcidin levels were compared to ferritin and hemoglobin levels using multivariable repeated measures regression models. Hepcidin, ferritin and hemoglobin levels declined with increasing frequency of donation in the first-time/reactivated females. Hepcidin and ferritin levels correlated well with each other (Spearman's correlation of 0.74), but on average hepcidin varied more between donations for a given donor relative to ferritin. In a multivariable repeated measures regression model the predicted inter-donation decline in hemoglobin varied as a function of hepcidin and ferritin; hemoglobin was 0.51 g/dL lower for subjects with low (>45.7 ng/mL) or decreasing hepcidin and low ferritin (>26 ng/mL), and was essentially zero for other subjects including those with high (>45.7 ng/mL) or increasing hepcidin and low ferritin (>26 ng/mL) levels (P<0.001). In conclusion, hepcidin levels change rapidly in response to dietary iron needed for erythropoiesis. The dynamic regulation of hepcidin in the presence of a low levels of ferritin suggests that plasma hepcidin concentration may provide clinically useful information about an individual's iron status (and hence capacity to tolerate repeated blood donations) beyond that of ferritin alone. Clinicaltrials.gov identifier: NCT00097006.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23445875      PMCID: PMC3729915          DOI: 10.3324/haematol.2012.070979

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  22 in total

1.  Iron absorption. I. Factors influencing absorption.

Authors:  T H BOTHWELL; G PIRZIO-BIROLI; C A FINCH
Journal:  J Lab Clin Med       Date:  1958-01

Review 2.  Beta-thalassemia.

Authors:  Deborah Rund; Eliezer Rachmilewitz
Journal:  N Engl J Med       Date:  2005-09-15       Impact factor: 91.245

3.  Suppression of hepcidin during anemia requires erythropoietic activity.

Authors:  Mihwa Pak; Miguel A Lopez; Victroia Gabayan; Tomas Ganz; Seth Rivera
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

4.  Hepcidin in iron overload disorders.

Authors:  George Papanikolaou; Michalis Tzilianos; John I Christakis; Dionisios Bogdanos; Konstantina Tsimirika; Julie MacFarlane; Y Paul Goldberg; Nikos Sakellaropoulos; Tomas Ganz; Elizabeta Nemeth
Journal:  Blood       Date:  2005-01-25       Impact factor: 22.113

5.  Iron deficiency in blood donors: analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study.

Authors:  Ritchard G Cable; Simone A Glynn; Joseph E Kiss; Alan E Mast; Whitney R Steele; Edward L Murphy; David J Wright; Ronald A Sacher; Jerry L Gottschall; Vibha Vij; Toby L Simon
Journal:  Transfusion       Date:  2010-08-30       Impact factor: 3.157

6.  Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.

Authors:  Elizabeta Nemeth; Marie S Tuttle; Julie Powelson; Michael B Vaughn; Adriana Donovan; Diane McVey Ward; Tomas Ganz; Jerry Kaplan
Journal:  Science       Date:  2004-10-28       Impact factor: 47.728

7.  Demographic correlates of low hemoglobin deferral among prospective whole blood donors.

Authors:  Alan E Mast; Karen S Schlumpf; David J Wright; Brian Custer; Bryan Spencer; Edward L Murphy; Toby L Simon
Journal:  Transfusion       Date:  2010-04-15       Impact factor: 3.157

8.  Rapid identification of iron deficiency in blood donors with red cell indexes provided by Advia 120.

Authors:  Hartmut Radtke; Tina Meyer; Ulrich Kalus; Lothar Röcker; Abdulgabar Salama; Holger Kiesewetter; Reinhard Latza
Journal:  Transfusion       Date:  2005-01       Impact factor: 3.157

9.  Immunoassay for human serum hepcidin.

Authors:  Tomas Ganz; Gordana Olbina; Domenico Girelli; Elizabeta Nemeth; Mark Westerman
Journal:  Blood       Date:  2008-08-08       Impact factor: 22.113

10.  Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis.

Authors:  M Vokurka; J Krijt; K Sulc; E Necas
Journal:  Physiol Res       Date:  2006       Impact factor: 1.881

View more
  8 in total

1.  Genetic and behavioral modification of hemoglobin and iron status among first-time and high-intensity blood donors.

Authors:  Alan E Mast; John C Langer; Yuelong Guo; Walter Bialkowski; Bryan R Spencer; Tzong-Hae Lee; Joseph Kiss; Ritchard G Cable; Donald Brambilla; Michael P Busch; Grier P Page
Journal:  Transfusion       Date:  2020-03-12       Impact factor: 3.157

Review 2.  Low hemoglobin deferral in blood donors.

Authors:  Alan E Mast
Journal:  Transfus Med Rev       Date:  2013-11-12

3.  Hepcidin as a predictive factor and therapeutic target in erythropoiesis-stimulating agent treatment for anemia of chronic disease in rats.

Authors:  Milan Theurl; Manfred Nairz; Andrea Schroll; Thomas Sonnweber; Malte Asshoff; David Haschka; Markus Seifert; Wolfgang Willenbacher; Doris Wilflingseder; Wilfried Posch; Anthony T Murphy; Derrick R Witcher; Igor Theurl; Günter Weiss
Journal:  Haematologica       Date:  2014-06-03       Impact factor: 9.941

4.  2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium.

Authors:  Steven L Spitalnik; Darrell Triulzi; Dana V Devine; Walter H Dzik; Anne F Eder; Terry Gernsheimer; Cassandra D Josephson; Daryl J Kor; Naomi L C Luban; Nareg H Roubinian; Traci Mondoro; Lisbeth A Welniak; Shimian Zou; Simone Glynn
Journal:  Transfusion       Date:  2015-08-10       Impact factor: 3.157

5.  Altered erythropoiesis and iron metabolism in carriers of thalassemia.

Authors:  Jacqueline S Guimarães; Juçara G Cominal; Ana Cristina Silva-Pinto; Gordana Olbina; Yelena Z Ginzburg; Vijay Nandi; Mark Westerman; Stefano Rivella; Ana Maria de Souza
Journal:  Eur J Haematol       Date:  2014-11-11       Impact factor: 2.997

6.  Hepcidin is a Better Predictor of Iron Stores in Premenopausal Women than Blood Loss or Dietary Intake.

Authors:  Karen H C Lim; Alison O Booth; Caryl A Nowson; Ewa A Szymlek-Gay; David O Irving; Lynn J Riddell
Journal:  Nutrients       Date:  2016-09-02       Impact factor: 5.717

7.  Ferritin Trajectories over Repeated Whole Blood Donations: Results from the FIND+ Study.

Authors:  Sara Moazzen; Maike G Sweegers; Mart Janssen; Boris M Hogema; Trynke Hoekstra; Katja Van den Hurk
Journal:  J Clin Med       Date:  2022-06-21       Impact factor: 4.964

8.  NTBI levels in C282Y homozygotes after therapeutic phlebotomy.

Authors:  Eleanor Ryan; Keith Mulready; Erwin Wiegerinck; Jennifer Russell; Dorine W Swinkels; Stephen Stewart
Journal:  EJHaem       Date:  2022-07-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.